浩欧博(688656)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688656 浩欧博

已收盘 04-16 15:00:01

{"stockData":{"symbol":"688656","market":"SH","secType":"STK","nameCN":"浩欧博","latestPrice":138.5,"timestamp":1776322801000,"preClose":136.63,"halted":0,"volume":363020,"delay":0,"changeRate":0.0137,"floatShares":63479700,"shares":63479700,"eps":0.1512,"marketStatus":"已收盘","change":1.87,"latestTime":"04-16 15:00:01","open":137.19,"high":139.87,"low":135.2,"amount":49974200,"amplitude":0.0342,"askPrice":138.5,"askSize":11,"bidPrice":138.23,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.1512,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776389400000},"marketStatusCode":5,"adr":0,"adjPreClose":136.63,"symbolType":"stock_kcb","openAndCloseTimeList":[[1776303000000,1776310200000],[1776315600000,1776322800000]],"highLimit":150.29,"lowLimit":122.97,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":63479740,"isCdr":false,"pbRate":10.72,"roa":"--","peRate":916.005291,"roe":"2.84%","epsLYR":0.37,"committee":-0.528455,"marketValue":8792000000,"turnoverRate":0.0057,"status":0,"afterMarket":{"amount":0,"volume":0,"close":138.5,"buyVolume":0,"sellVolume":0,"time":1776324837558,"indexStatus":"已收盘 04-16 15:30:00","preClose":136.63},"floatMarketCap":8792000000},"requestUrl":"/m/hq/s/688656","defaultTab":"news","newsList":[{"id":"2625410616","title":"每周股票复盘：浩欧博（688656）2025年净利降36.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625410616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625410616?lang=zh_cn&edition=full","pubTime":"2026-04-05 02:19","pubTimestamp":1775326749,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，浩欧博报收于132.16元，较上周的125.18元上涨5.58%。本周，浩欧博4月1日盘中最高价报143.0元。浩欧博当前最新总市值83.89亿元，在医疗器械板块市值排名43/129，在两市A股市值排名2193/5193。江苏浩欧博生物医药股份有限公司召开2025年年度股东会，审议2025年年度报告、董事会工作报告、财务决算报告、利润分配方案等议案。2025年公司实现营业收入39,839.98万元，同比下降0.98%；归属于上市公司股东的净利润2,320.08万元，同比下降36.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624659124","title":"浩欧博（688656）披露2025年年度股东会会议资料，4月3日股价上涨2.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624659124","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624659124?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:41","pubTimestamp":1775209276,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，浩欧博报收于132.16元，较前一交易日上涨2.36%，最新总市值为83.89亿元。近日，江苏浩欧博生物医药股份有限公司披露《2025年年度股东会会议资料》。公告显示，公司拟召开2025年年度股东会，审议2025年年度报告、董事会工作报告、财务决算报告、利润分配方案等议案。2025年公司实现营业收入39,839.98万元，同比下降0.98%；归属于上市公司股东的净利润2,320.08万元，同比下降36.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622893752","title":"股市必读：浩欧博（688656）今年截至3月26日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622893752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622893752?lang=zh_cn&edition=full","pubTime":"2026-03-27 02:57","pubTimestamp":1774551428,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，浩欧博报收于121.39元，下跌2.21%，换手率0.53%，成交量3336.0手，成交额4125.63万元。当日关注点来自交易信息汇总：浩欧博3月26日收盘报121.39元，跌2.21%，当日成交33.36万元，年内累计跌幅达20.84%。来自资金流向：主力资金3月26日净流出156.56万元，前10个交易日累计净流出1535.02万元，同期股价下跌12.72%。交易信息汇总浩欧博3月26日收盘价为121.39元，下跌2.21%，当日成交额为33.36万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700004587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621765017","title":"3月23日浩欧博跌10.81%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621765017","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621765017?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:42","pubTimestamp":1774255368,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日浩欧博跌10.81%创60日新低，收盘报119.5元，换手率1.39%，成交量8827.0手，成交额1.1亿元。该股为医疗器械、体外诊断概念热股。重仓浩欧博的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。该公募基金现任基金经理为梦圆。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621915897","title":"每周股票复盘：浩欧博（688656）2025年净利降36.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621915897","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621915897?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:31","pubTimestamp":1774121469,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，浩欧博报收于133.99元，较上周的138.04元下跌2.93%。本周关注点来自业绩披露要点：浩欧博2025年归母净利润2320.08万元，同比下降36.96%。股本股东变化截至2026年2月28日，浩欧博股东户数为3704.0户，较2025年12月31日减少203.0户，减幅5.2%。2025年扣除脱敏药业务后实际归母净利润为4,984.82万元，完成率为95.53%；扣非净利润为4,132.46万元，完成率86.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200001353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620651212","title":"股市必读：浩欧博年报 - 第四季度单季净利润同比下降129.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620651212","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620651212?lang=zh_cn&edition=full","pubTime":"2026-03-19 01:31","pubTimestamp":1773855069,"startTime":"0","endTime":"0","summary":"来自：浩欧博2025年归母净利润同比下降36.96%，但第四季度营收同比增长11.45%。2025年度归母净利润承诺不低于5,218.00万元，扣非归母净利润不低于4,774.00万元。实际扣除脱敏药业务后归母净利润为4,984.82万元，完成率95.53%；扣非归母净利润为4,132.46万元，完成率86.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900000800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620126252","title":"浩欧博（688656）披露全资子公司获得两项医疗器械注册证，3月18日股价上涨0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620126252","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620126252?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:32","pubTimestamp":1773844336,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘，浩欧博报收于142.03元，较前一交易日上涨0.69%，最新总市值为90.16亿元。该股当日开盘144.0元，最高144.34元，最低137.49元，成交额达5652.8万元，换手率为0.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800040822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09996","BK1100","BK1222","688656","BK0239","09997","159883","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620690233","title":"浩欧博(688656.SH)子公司获得2项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2620690233","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620690233?lang=zh_cn&edition=full","pubTime":"2026-03-18 16:03","pubTimestamp":1773821033,"startTime":"0","endTime":"0","summary":"浩欧博(688656.SH)发布公告，公司全资子公司湖南浩欧博生物医药有限公司于近日获得2项由湖南省药品监督管理局核准签发的医疗器械注册证，涉及产品：“抗丙氨酰tRNA合成酶(PL-12)抗体检测试剂盒(磁微粒化学发光法)”、“抗苏氨酰tRNA合成酶(PL-7)抗体检测试剂盒(磁微粒化学发光法)”。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/2.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/2.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["09996","09997","BK0239","159883","BK1574","688656","BK1222","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620429657","title":"浩欧博最新公告：2025年净利润同比下降36.96%拟10派2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620429657","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620429657?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:19","pubTimestamp":1773746391,"startTime":"0","endTime":"0","summary":"浩欧博(688656.SH)披露年度报告，2025年实现营业收入3.98亿元，同比下降0.98%；归母净利润2320.08万元，同比下降36.96%；基本每股收益0.37元。公司拟向全体股东每10股派发现金红利2元（含税）。报告期内，受市场宏观环境影响，公司产品销售规模出现小幅下滑。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700035727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618980665","title":"3月10日浩欧博涨5.19%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618980665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618980665?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:23","pubTimestamp":1773130982,"startTime":"0","endTime":"0","summary":"证券之星消息，3月10日浩欧博涨5.19%，收盘报145.03元，换手率1.03%，成交量6538.0手，成交额9357.66万元。该股为医疗器械、体外诊断概念热股。重仓浩欧博的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。该公募基金现任基金经理为梦圆。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000024290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617668042","title":"每周股票复盘：浩欧博（688656）全资子公司获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2617668042","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617668042?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:40","pubTimestamp":1772908822,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，浩欧博报收于139.1元，较上周的142.78元下跌2.58%。本周，浩欧博3月2日盘中最高价报146.57元。本周关注点公司公告汇总：全资子公司湖南浩欧博获抗SRP抗体检测试剂盒医疗器械注册证公司公告汇总江苏浩欧博生物医药股份有限公司全资子公司湖南浩欧博生物医药有限公司近日获得湖南省药品监督管理局核发的医疗器械注册证，产品为抗信号识别粒子抗体检测试剂盒，注册证编号湘械注准20262400086，有效期至2031年2月11日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","09996","688656","159883","BK1100","BK1222","09997","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616735695","title":"浩欧博（688656）披露全资子公司获得医疗器械注册证，3月2日股价下跌0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616735695","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616735695?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:02","pubTimestamp":1772463746,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，浩欧博报收于141.73元，较前一交易日下跌0.74%，最新总市值为89.97亿元。江苏浩欧博生物医药股份有限公司近日披露公告，其全资子公司湖南浩欧博生物医药有限公司获得湖南省药品监督管理局核发的医疗器械注册证，产品为抗信号识别粒子抗体检测试剂盒，注册证编号湘械注准20262400086，有效期至2031年2月11日。该试剂盒用于体外定性检测血清样本中抗SRP抗体，临床上主要用于免疫介导性坏死性肌病的辅助诊断。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","688656","BK0239","BK1574","BK1100","BK1222","09997","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616809533","title":"浩欧博(688656.SH)子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2616809533","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616809533?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:47","pubTimestamp":1772444869,"startTime":"0","endTime":"0","summary":"智通财经APP讯，浩欧博(688656.SH)发布公告，公司全资子公司湖南浩欧博生物医药有限公司于近日获得1项由湖南省药品监督管理局核准签发的医疗器械注册证，产品名称：抗信号识别粒子(SRP)抗体检测试剂盒(磁微粒化学发光法)。该试剂盒用于体外定性检测血清样本中抗信号识别粒子(SRP)抗体，临床上主要用于免疫介导性坏死性肌病的辅助诊断。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1583","BK1100","BK1222","BK0239","159883","09997","688656","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616184590","title":"每周股票复盘：浩欧博（688656）2025年净利降36.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616184590","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616184590?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:58","pubTimestamp":1772305090,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，浩欧博报收于142.78元，较上周的147.61元下跌3.27%。本周，浩欧博2月24日盘中最高价报150.9元。本周关注点业绩披露要点：浩欧博2025年归属净利润同比减少36.37%。公司公告汇总：浩欧博2025年营业总收入为398,399,778.38元，同比下降0.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614045881","title":"浩欧博(688656.SH)2025年度归母净利润2341.81万元 同比下降36.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045881","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614045881?lang=zh_cn&edition=full","pubTime":"2026-02-26 19:56","pubTimestamp":1772106985,"startTime":"0","endTime":"0","summary":"智通财经APP讯，浩欧博 发布2025年度业绩快报，报告期内公司实现营业收入39,839.98万元，较上年同期下降0.98%;实现归属于母公司所有者的净利润2,341.81万元，较上年同期下降36.37%。报告期内，①受宏观市场环境及相关政策调整影响，公司整体销售规模略有下滑，对营业收入、净利润等财务指标构成一定影响;②随着公司自动化仪器投放规模持续扩大，相关资产折旧费用相应增加，直接导致公司整体成本总额有所上升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"浩欧博(688656.SH)2025年度归母净利润2341.81万元 同比下降36.37%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614401668","title":"浩欧博发布2025年度业绩快报，盈利0.234亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614401668","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614401668?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:13","pubTimestamp":1772097232,"startTime":"0","endTime":"0","summary":"证券之星消息，浩欧博近日即将发布2025年年报，根据2月26日发布的业绩快报，归属净利润盈利0.234亿元，同比减少36.37%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600025795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613795581","title":"2月24日浩欧博跌6.16%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613795581","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613795581?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:27","pubTimestamp":1771921636,"startTime":"0","endTime":"0","summary":"证券之星消息，2月24日浩欧博跌6.16%创60日新低，收盘报138.51元，换手率1.89%，成交量1.2万手，成交额1.69亿元。重仓浩欧博的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。该公募基金现任基金经理为梦圆。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400030115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595276290","title":"12月30日浩欧博跌7.66%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595276290","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595276290?lang=zh_cn&edition=full","pubTime":"2025-12-30 15:34","pubTimestamp":1767080095,"startTime":"0","endTime":"0","summary":"证券之星消息，12月30日浩欧博跌7.66%，收盘报167.23元，换手率2.27%，成交量1.44万手，成交额2.5亿元。该股为医疗器械、体外诊断概念热股。重仓浩欧博的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。该公募基金现任基金经理为梦圆。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000020267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592978126","title":"12月18日浩欧博跌7.25%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592978126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592978126?lang=zh_cn&edition=full","pubTime":"2025-12-18 15:34","pubTimestamp":1766043244,"startTime":"0","endTime":"0","summary":"证券之星消息，12月18日浩欧博跌7.25%，收盘报182.25元，换手率2.28%，成交量1.44万手，成交额2.68亿元。重仓浩欧博的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。该公募基金现任基金经理为梦圆。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800017850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591404609","title":"12月16日浩欧博跌5.52%，农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591404609","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591404609?lang=zh_cn&edition=full","pubTime":"2025-12-16 15:36","pubTimestamp":1765870602,"startTime":"0","endTime":"0","summary":"证券之星消息，12月16日浩欧博跌5.52%，收盘报196.69元，换手率1.31%，成交量8311.0手，成交额1.65亿元。该股为医疗器械、体外诊断概念热股。重仓浩欧博的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为农银汇理基金的农银医疗保健股票。该公募基金现任基金经理为梦圆。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600020151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688656","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776327381249,"stockEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":-0.0311},{"period":"3month","weight":-0.1142},{"period":"6month","weight":-0.1203},{"period":"1year","weight":0.5722},{"period":"ytd","weight":-0.1116}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":-0.0141},{"period":"3month","weight":-0.0208},{"period":"6month","weight":0.0488},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏浩欧博生物医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"3704人(较上一季度减少5.20%)","perCapita":"17138股","listingDate":"2021-01-13","address":"江苏省苏州市虎丘区中国(江苏)自由贸易试验区苏州片区苏州工业园区东堰里路9号","registeredCapital":"6347万元","survey":"　　江苏浩欧博生物医药股份有限公司的主营业务是体外诊断试剂的研发、生产和销售。公司的主要产品是过敏试剂、自免试剂。截至报告期末，公司已获234项产品注册证书，64项专利。公司为高新技术企业，曾先后被评为“江苏省免疫诊断工程技术研究中心”,“江苏省过敏原诊断工程技术研究中心”,“省级工业企业技术中心”，荣获苏州市“创新先锋企业”,“瞪羚企业”,“五星级信用企业”,“企业信用评价3A级信用企业”,“科技企业上市奖”“安全生产月优秀组织奖”,“2021年江苏医学科技奖二等奖”及“苏州市生物医药产业潜力地标企业”,“江苏省专精特新中小企业”“安全生产党员先锋岗”,“医疗器械产业专项奖”“苏州市总部企业”,“国家级专精特新‘小巨人’企业”等荣誉称号。","listedPrice":35.26},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"浩欧博(688656)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供浩欧博(688656)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"浩欧博,688656,浩欧博股票,浩欧博股票老虎,浩欧博股票老虎国际,浩欧博行情,浩欧博股票行情,浩欧博股价,浩欧博股市,浩欧博股票价格,浩欧博股票交易,浩欧博股票购买,浩欧博股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"浩欧博(688656)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供浩欧博(688656)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}